Gilead, Precision to co-develop hepatitis B therapies
admin 13th September 2018 Uncategorised 0Gilead and Precision BioSciences are to work together on developing gene-editing treatments against hepatitis B.
More: Gilead, Precision to co-develop hepatitis B therapies
Source: News
